Financial & competing interests disclosure
SJ Nicholls has received research support from Amgen, AstraZeneca, Anthera, Eli Lilly, InfraReDx, LipoScience, Novartis, Resverlogix and Roche and is a consultant for AstraZeneca, Atheronova, Boehringer Ingelheim, CSL Behring, Eli Lilly, LipoScience, Merck, Resverlogix, Roche, Sanofi-Aventis and Takeda. The authors have no other relevant affiliations or financial involvement with any organization or entity with a financial interest in or financial conflict with the subject matter or materials discussed in the manuscript apart from those disclosed.
No writing assistance was utilized in the production of this manuscript.